Anticoagulant-induced Bleeding, Cardiovascular Stroke, Chronic Subdural Hematoma, Thromboembolic Stroke
Conditions
Keywords
chronic subdural hematoma, anticoagulants, antithrombotics, thromboembolic disease, cardiovascular risk
Brief summary
Primary objective of the study will be to compare, up to 6 months after surgery, number of relapses (post operative re-bleeding) or intracerebral hemorrhage (others than subdural hematomas) and thromboembolic or cardiovascular ischemic events, in patients undergoing surgery for chronic subdural hematoma (CSDH). These data will be correlated to the suspension or not of antithrombotics or anticoagulants before surgery or their re-introduction after surgery.
Interventions
PROCEDURECSDH evacuation
Burr hole for chronic subdural hematomas
Sponsors
University Hospital of Ferrara
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years old * Informed consent * Evidence of CSDH which needs surgery * patients taking antithrombotics or anticoagulants
Exclusion criteria
* previous surgery for CSDH
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| hemorrhagic or thromboembolic events evaluation | up to 6 months after surgery | hemorrhagic (re-bleedings in surgical field, other cerebral bleedings); thromboembolic events(acute ischemic stroke, acute myocardial infarction, pulmunoray embolism, deep venous thrombosis) |
Countries
Italy
Outcome results
None listed